Company Mizuho Medy Co.,Ltd.

Equities

4595

JP3885900005

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Ratings for Mizuho Medy Co.,Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
3,305 ^JPY	-0.45%		+2.01%	+5.25%

2021	Mizuho Medy Co.,Ltd.(TSE:4595) added to S&P Global BMI Index	CI
2020	Mizuho Medy Co.,Ltd.(TSE:4595) dropped from S&P Global BMI Index	CI

MIZUHO MEDY CO., LTD. is a Japan-based company principally engaged in-vitro diagnostic pharmaceuticals business. The Company mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Number of employees: 180

JPY in Million	2022	Weight	2023	Weight	Delta
Hospitals and Practitioner - New Coronavirus Test Drug 69.3 %	15,179	86.3 %	7,617	69.3 %	-49.82%
Hospitals and Practitioner - Other Testing Agents and Equipment 18.8 %	1,641	9.3 %	2,070	18.8 %	+26.20%
Hospitals and Practitioner - Influenza Test Drug 8.6 %	416	2.4 %	949	8.6 %	+128.16%
Over-the-counter and Other Fields 3.2 %	346	2.0 %	353	3.2 %	+2.05%

JPY in Million	2022	Weight	2023	Weight	Delta
Japan 100.0 %	17,582	100.0 %	10,990	100.0 %	-37.49%

Managers	Title	Age	Since
Fuminari Karakawa FOU	Founder	79	77-11-01
Tadashi Imamura CTO	Chief Tech/Sci/R&D Officer	65	84-03-31
Toshio Kambara BRD	Director/Board Member	60	94-09-30
Kazuhiro Ichimaru BRD	Director/Board Member	63	86-10-31
Kenji Narahara BRD	Director/Board Member	60	86-03-31
Hiroshi Sasaki BRD	Director/Board Member	61	89-05-31
Hirotaka Kawasaki AUD	Comptroller/Controller/Auditor	65	86-03-31

Members of the board	Title	Age	Since
Katsumi Sasaki BRD	Director/Board Member	79	15-02-28
Fuminari Karakawa FOU	Founder	79	77-11-01
Tadashi Imamura CTO	Chief Tech/Sci/R&D Officer	65	84-03-31
Hiroshi Sasaki BRD	Director/Board Member	61	89-05-31
Kenji Narahara BRD	Director/Board Member	60	86-03-31
Kazuhiro Ichimaru BRD	Director/Board Member	63	86-10-31
Toshio Kambara BRD	Director/Board Member	60	94-09-30
Shinichi Akiyama BRD	Director/Board Member	79	17-02-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	9,525,600	5,107,397 ( 53.62 %)	1,203 ( 0.0126 %)	53.62 %

Name	Equities	%	Valuation
Fuminari Karakawa 35.63 %	3,394,000	35.63 %	75 M ¥
Mizuho Medy Employee Stock Ownership Plan 3.160 %	301,000	3.160 %	7 M ¥
Akitomo Nakajima 2.562 %	244,000	2.562 %	5 M ¥
NISHI-NIPPON FINANCIAL HOLDINGS, INC. 2.100 %	200,000	2.100 %	4 M ¥
Sadanori Tateishi 1.995 %	190,000	1.995 %	4 M ¥
Koji Kitajima 1.155 %	110,000	1.155 %	2 M ¥
Kazuya Yamaguchi 1.113 %	106,000	1.113 %	2 M ¥
Junichi Murata 1.092 %	104,000	1.092 %	2 M ¥
Kameshiro Watanabe 1.060 %	101,000	1.060 %	2 M ¥
Noriyasu Karakawa 1.050 %	100,000	1.050 %	2 M ¥

Name	Equities	%	Valuation
MIZUHO MEDY CO.,LTD. 0.01%	1,100	0.01%	24,457 $
VITAL KSK HOLDINGS, INC. 0.00%	1,000	0.00%	8,299 $

Mizuho Medy Co., Ltd.

5-4 Fujinoki-machi

841-0048, Tosu

http://www.mizuho-m.co.jp

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
MIZUHO MEDY CO.,LTD.	+5.25%	200M
BIOMÉRIEUX	+0.89%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-10.29%	7.61B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.16%	4.51B
LANTHEUS HOLDINGS, INC.	+5.74%	4.49B
10X GENOMICS, INC.	-50.70%	3.3B
ANDON HEALTH CO., LTD.	+12.21%	2.73B
VITROLIFE AB	-16.13%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.50%	1.73B
MYRIAD GENETICS, INC.	-5.02%	1.64B

Diagnostic & Testing Substances